1. The prevalence of antibodies to simian T-cell leukaemia/lymphotropic virus (STLV-I) in non-human primate colonies in Kenya
- Author
-
Daudi K. Langat, M. W. Sichangi, M. Isahakia, E. J. Van Rensburg, and Jason M. Mwenda
- Subjects
Primates ,viruses ,Blotting, Western ,030231 tropical medicine ,Simian ,Antibodies, Viral ,Virus ,03 medical and health sciences ,0302 clinical medicine ,030225 pediatrics ,hemic and lymphatic diseases ,biology.animal ,Chlorocebus aethiops ,Prevalence ,Animals ,Primate ,Non human primate ,biology ,biology.organism_classification ,Kenya ,Virology ,Infectious Diseases ,Virus type ,biology.protein ,Parasitology ,Viral disease ,Antibody ,Simian T-lymphotropic virus 1 ,T cell leukaemia ,Papio - Abstract
Retroviruses closely related to the human T-cell leukaemia/lymphotrophic virus type I (HTLV-I) have been detected in several, non-human, primate species. These retroviruses are called simian T-lymphotrophic virus type I (STLV-I). Infection with STLV-I has been associated with lymphoma and leukaemia in macaques, baboons, African green monkeys and gorillas. However, no STLV-I infection has been detected in New World primates, although STLV-II has been detected in spider monkeys. When sera from 10 species of non-human primates maintained at the Institute of Primate Research were screened for STLV-I infection, anti-STLV-I antibodies were detected in 12%, 12%, 23% and 38% of the olive baboons, yellow baboons, African green monkeys and lowland Sykes' monkeys, respectively. Western-blot studies confirmed these results. To date, no clinical disease has been linked with STLV-I infection in these colonies. The relatively high prevalence of anti-STLV-I antibodies in these non-human primates offers an opportunity for studies on the transmission, phylogenetic relationships and natural history of STLV-I in primate colonies.
- Published
- 1999
- Full Text
- View/download PDF